BIIB100 / Biogen, Karyopharm  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIIB100 / Biogen
NCT03945279: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis

Completed
1
49
US
BIIB100, Placebo
Biogen
Amyotrophic Lateral Sclerosis
06/21
06/21

Download Options